Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Otolaryngology | 16 | 2024 | 685 | 4.130 |
Why?
|
Cochlear Implantation | 8 | 2021 | 315 | 2.780 |
Why?
|
Otitis Media with Effusion | 4 | 2023 | 114 | 2.440 |
Why?
|
Hearing Loss, Sensorineural | 8 | 2022 | 781 | 2.330 |
Why?
|
Cochlear Implants | 7 | 2021 | 338 | 2.240 |
Why?
|
Neuroma, Acoustic | 4 | 2024 | 459 | 2.150 |
Why?
|
Hearing Loss | 6 | 2022 | 780 | 2.130 |
Why?
|
Tympanic Membrane | 3 | 2024 | 232 | 1.460 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2557 | 1.410 |
Why?
|
Hearing Aids | 2 | 2022 | 58 | 1.310 |
Why?
|
Lipoma | 3 | 2015 | 292 | 1.200 |
Why?
|
Meniere Disease | 3 | 2021 | 163 | 1.120 |
Why?
|
Tympanic Membrane Perforation | 2 | 2024 | 45 | 1.020 |
Why?
|
Vocal Cord Paralysis | 2 | 2019 | 272 | 1.000 |
Why?
|
Otitis Media | 3 | 2023 | 285 | 0.940 |
Why?
|
Hearing Tests | 5 | 2022 | 121 | 0.920 |
Why?
|
Hearing Loss, Sudden | 3 | 2021 | 45 | 0.910 |
Why?
|
Cerebellopontine Angle | 2 | 2014 | 53 | 0.880 |
Why?
|
Sleep Apnea, Central | 1 | 2023 | 88 | 0.790 |
Why?
|
Vestibular Diseases | 3 | 2021 | 229 | 0.750 |
Why?
|
Otorhinolaryngologic Diseases | 2 | 2019 | 95 | 0.740 |
Why?
|
Middle Ear Ventilation | 2 | 2021 | 99 | 0.700 |
Why?
|
Otitis Externa | 2 | 2016 | 17 | 0.690 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 587 | 0.620 |
Why?
|
Speech Perception | 2 | 2022 | 505 | 0.620 |
Why?
|
Brain Stem | 2 | 2014 | 857 | 0.610 |
Why?
|
Mastoiditis | 1 | 2018 | 37 | 0.600 |
Why?
|
Equipment Failure Analysis | 1 | 2020 | 848 | 0.590 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2020 | 149 | 0.580 |
Why?
|
Hemangioma, Capillary | 1 | 2017 | 62 | 0.550 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2024 | 323 | 0.540 |
Why?
|
Ear Neoplasms | 1 | 2017 | 118 | 0.540 |
Why?
|
Second-Look Surgery | 1 | 2016 | 27 | 0.540 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2016 | 50 | 0.520 |
Why?
|
Internet | 2 | 2020 | 3078 | 0.520 |
Why?
|
Eustachian Tube | 1 | 2017 | 96 | 0.520 |
Why?
|
Tympanoplasty | 1 | 2016 | 72 | 0.520 |
Why?
|
Community Networks | 1 | 2017 | 201 | 0.510 |
Why?
|
Databases, Factual | 13 | 2021 | 8035 | 0.510 |
Why?
|
Microcomputers | 1 | 2015 | 141 | 0.510 |
Why?
|
Pharyngeal Neoplasms | 1 | 2015 | 113 | 0.500 |
Why?
|
Corynebacterium | 1 | 2015 | 47 | 0.490 |
Why?
|
Public Sector | 1 | 2017 | 265 | 0.490 |
Why?
|
Corynebacterium Infections | 1 | 2015 | 27 | 0.490 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2020 | 364 | 0.490 |
Why?
|
Thoracic Surgical Procedures | 1 | 2019 | 348 | 0.490 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 159 | 0.490 |
Why?
|
Sleep Apnea Syndromes | 1 | 2023 | 974 | 0.480 |
Why?
|
Esophagectomy | 1 | 2018 | 466 | 0.480 |
Why?
|
Osseointegration | 1 | 2016 | 274 | 0.470 |
Why?
|
Triage | 1 | 2021 | 987 | 0.470 |
Why?
|
Retirement | 1 | 2015 | 199 | 0.460 |
Why?
|
Vocal Cords | 1 | 2018 | 523 | 0.460 |
Why?
|
North Carolina | 4 | 2020 | 325 | 0.460 |
Why?
|
Tonsillectomy | 1 | 2017 | 268 | 0.450 |
Why?
|
Private Sector | 1 | 2017 | 397 | 0.440 |
Why?
|
Humans | 76 | 2024 | 760621 | 0.440 |
Why?
|
Dizziness | 3 | 2023 | 257 | 0.430 |
Why?
|
Deglutition Disorders | 1 | 2019 | 626 | 0.430 |
Why?
|
Academic Medical Centers | 4 | 2015 | 2754 | 0.420 |
Why?
|
Diuretics | 1 | 2016 | 613 | 0.420 |
Why?
|
Sarcoma, Synovial | 1 | 2014 | 151 | 0.420 |
Why?
|
Health Resources | 1 | 2018 | 935 | 0.400 |
Why?
|
Hospital Administration | 1 | 2015 | 355 | 0.400 |
Why?
|
Writing | 1 | 2013 | 199 | 0.380 |
Why?
|
Efficiency, Organizational | 1 | 2015 | 697 | 0.370 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5325 | 0.360 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1677 | 0.350 |
Why?
|
Microsurgery | 1 | 2015 | 796 | 0.340 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2023 | 1860 | 0.340 |
Why?
|
Drainage | 1 | 2015 | 1161 | 0.340 |
Why?
|
Retrospective Studies | 24 | 2023 | 80372 | 0.340 |
Why?
|
Population Surveillance | 1 | 2020 | 2608 | 0.330 |
Why?
|
Wounds and Injuries | 1 | 2022 | 2477 | 0.320 |
Why?
|
Hypersensitivity | 1 | 2017 | 1155 | 0.310 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 3164 | 0.300 |
Why?
|
Endoscopy | 3 | 2024 | 1838 | 0.290 |
Why?
|
Algorithms | 7 | 2023 | 13981 | 0.290 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7408 | 0.290 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1796 | 0.280 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1204 | 0.280 |
Why?
|
Publishing | 1 | 2013 | 836 | 0.260 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1673 | 0.260 |
Why?
|
Postoperative Complications | 2 | 2018 | 15697 | 0.260 |
Why?
|
Teaching | 1 | 2013 | 1169 | 0.260 |
Why?
|
Adult | 24 | 2022 | 219994 | 0.260 |
Why?
|
Ear Diseases | 2 | 2018 | 177 | 0.260 |
Why?
|
Male | 30 | 2024 | 359744 | 0.250 |
Why?
|
Health Services Accessibility | 3 | 2017 | 5397 | 0.240 |
Why?
|
Otoscopy | 2 | 2021 | 40 | 0.230 |
Why?
|
Child | 14 | 2023 | 79806 | 0.230 |
Why?
|
Female | 30 | 2023 | 391270 | 0.220 |
Why?
|
Canada | 3 | 2021 | 2128 | 0.220 |
Why?
|
Aged, 80 and over | 10 | 2022 | 58995 | 0.220 |
Why?
|
Seasons | 2 | 2022 | 1522 | 0.220 |
Why?
|
Air Pressure | 1 | 2023 | 74 | 0.220 |
Why?
|
Health Care Costs | 1 | 2016 | 3258 | 0.220 |
Why?
|
Medicaid | 1 | 2016 | 2815 | 0.210 |
Why?
|
Quality of Life | 4 | 2021 | 13308 | 0.210 |
Why?
|
Electronic Health Records | 3 | 2021 | 4775 | 0.200 |
Why?
|
Otologic Surgical Procedures | 1 | 2023 | 149 | 0.200 |
Why?
|
Registries | 1 | 2018 | 8469 | 0.200 |
Why?
|
Aged | 16 | 2023 | 169152 | 0.200 |
Why?
|
Immunotherapy | 1 | 2017 | 4642 | 0.190 |
Why?
|
Depression | 1 | 2021 | 8044 | 0.190 |
Why?
|
Vertigo | 1 | 2023 | 202 | 0.190 |
Why?
|
Adolescent | 13 | 2018 | 87810 | 0.180 |
Why?
|
Middle Aged | 19 | 2023 | 220352 | 0.180 |
Why?
|
Voice | 1 | 2023 | 267 | 0.180 |
Why?
|
United States | 10 | 2022 | 72461 | 0.180 |
Why?
|
Voice Disorders | 1 | 2023 | 286 | 0.170 |
Why?
|
Students, Medical | 1 | 2013 | 1927 | 0.170 |
Why?
|
Sex Reassignment Procedures | 1 | 2020 | 64 | 0.170 |
Why?
|
Audiometry | 1 | 2020 | 253 | 0.170 |
Why?
|
Intraoperative Period | 1 | 2021 | 516 | 0.170 |
Why?
|
Models, Anatomic | 1 | 2023 | 682 | 0.170 |
Why?
|
Cost-Benefit Analysis | 3 | 2017 | 5508 | 0.170 |
Why?
|
Health Personnel | 1 | 2013 | 3310 | 0.170 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2882 | 0.170 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.170 |
Why?
|
Forecasting | 2 | 2020 | 2932 | 0.160 |
Why?
|
Hyperplasia | 1 | 2022 | 1155 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36290 | 0.160 |
Why?
|
Voice Quality | 1 | 2020 | 226 | 0.160 |
Why?
|
Nose | 1 | 2022 | 519 | 0.160 |
Why?
|
Empty Sella Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
|
Noise | 1 | 2020 | 280 | 0.150 |
Why?
|
Urban Population | 2 | 2017 | 2022 | 0.150 |
Why?
|
Ergolines | 1 | 2018 | 57 | 0.150 |
Why?
|
Treatment Outcome | 11 | 2023 | 65017 | 0.150 |
Why?
|
Optic Chiasm | 1 | 2018 | 91 | 0.150 |
Why?
|
Neck | 1 | 2022 | 731 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1725 | 0.150 |
Why?
|
Physicians | 1 | 2015 | 4591 | 0.140 |
Why?
|
Tinnitus | 1 | 2020 | 194 | 0.140 |
Why?
|
Prolactinoma | 1 | 2018 | 113 | 0.140 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11891 | 0.140 |
Why?
|
Polymyxin B | 1 | 2016 | 44 | 0.140 |
Why?
|
Neomycin | 1 | 2016 | 93 | 0.140 |
Why?
|
Ofloxacin | 1 | 2016 | 66 | 0.140 |
Why?
|
Head | 1 | 2022 | 922 | 0.130 |
Why?
|
Child, Preschool | 7 | 2018 | 42063 | 0.130 |
Why?
|
Vestibular Function Tests | 1 | 2016 | 128 | 0.130 |
Why?
|
Mouth Neoplasms | 1 | 2021 | 593 | 0.130 |
Why?
|
Rural Population | 2 | 2017 | 2268 | 0.130 |
Why?
|
Mastoid | 1 | 2016 | 98 | 0.130 |
Why?
|
Decision Trees | 1 | 2017 | 506 | 0.130 |
Why?
|
State Medicine | 1 | 2017 | 213 | 0.120 |
Why?
|
Dopamine Agonists | 1 | 2018 | 352 | 0.120 |
Why?
|
Mexican Americans | 1 | 2016 | 165 | 0.120 |
Why?
|
Administration, Intranasal | 1 | 2017 | 471 | 0.120 |
Why?
|
Headache | 1 | 2023 | 1249 | 0.120 |
Why?
|
Feasibility Studies | 2 | 2024 | 5201 | 0.120 |
Why?
|
Incidence | 3 | 2018 | 21392 | 0.120 |
Why?
|
Infant | 7 | 2021 | 36060 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6544 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2021 | 831 | 0.120 |
Why?
|
Health Services Research | 3 | 2016 | 1810 | 0.120 |
Why?
|
Ciprofloxacin | 1 | 2016 | 312 | 0.120 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 624 | 0.120 |
Why?
|
Young Adult | 8 | 2018 | 58741 | 0.120 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 385 | 0.110 |
Why?
|
Insurance, Health | 2 | 2017 | 2501 | 0.110 |
Why?
|
Recurrence | 2 | 2017 | 8482 | 0.110 |
Why?
|
International Classification of Diseases | 2 | 2016 | 894 | 0.110 |
Why?
|
Poverty Areas | 1 | 2015 | 264 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2021 | 1791 | 0.110 |
Why?
|
Comorbidity | 2 | 2018 | 10551 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 594 | 0.110 |
Why?
|
Administration, Topical | 1 | 2015 | 697 | 0.110 |
Why?
|
Fluoroquinolones | 1 | 2015 | 308 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22072 | 0.110 |
Why?
|
Insurance Claim Review | 1 | 2017 | 738 | 0.110 |
Why?
|
Neck Dissection | 1 | 2014 | 201 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2020 | 1489 | 0.100 |
Why?
|
Semicircular Canals | 1 | 2014 | 203 | 0.100 |
Why?
|
Bayes Theorem | 1 | 2020 | 2326 | 0.100 |
Why?
|
Prevalence | 3 | 2018 | 15687 | 0.100 |
Why?
|
Health Care Surveys | 2 | 2016 | 2435 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1677 | 0.100 |
Why?
|
Quality Indicators, Health Care | 1 | 2021 | 1824 | 0.090 |
Why?
|
Watchful Waiting | 1 | 2015 | 510 | 0.090 |
Why?
|
Cleft Palate | 1 | 2017 | 587 | 0.090 |
Why?
|
Postoperative Period | 1 | 2016 | 1818 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2021 | 2283 | 0.090 |
Why?
|
Drug Combinations | 1 | 2016 | 2025 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1758 | 0.090 |
Why?
|
Biopsy | 1 | 2022 | 6771 | 0.090 |
Why?
|
Drugs, Generic | 1 | 2015 | 448 | 0.090 |
Why?
|
Rare Diseases | 1 | 2015 | 619 | 0.090 |
Why?
|
Workload | 1 | 2015 | 847 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2015 | 843 | 0.080 |
Why?
|
Infant, Newborn | 4 | 2021 | 26181 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1313 | 0.080 |
Why?
|
Temporal Bone | 1 | 2014 | 683 | 0.080 |
Why?
|
Dexamethasone | 1 | 2016 | 1927 | 0.080 |
Why?
|
Age Factors | 2 | 2016 | 18416 | 0.080 |
Why?
|
Down Syndrome | 1 | 2017 | 892 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2016 | 1803 | 0.080 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1949 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2021 | 3598 | 0.080 |
Why?
|
Reoperation | 1 | 2018 | 4291 | 0.070 |
Why?
|
Medicare | 2 | 2016 | 6786 | 0.070 |
Why?
|
Quality Improvement | 2 | 2021 | 3836 | 0.070 |
Why?
|
Hearing | 2 | 2021 | 501 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5787 | 0.070 |
Why?
|
Sex Factors | 2 | 2020 | 10547 | 0.070 |
Why?
|
Preoperative Care | 1 | 2015 | 2256 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1868 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3618 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13314 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2014 | 3529 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2781 | 0.060 |
Why?
|
Risk Assessment | 2 | 2019 | 24123 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8624 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6479 | 0.060 |
Why?
|
Inpatients | 1 | 2015 | 2581 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3696 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12531 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6828 | 0.060 |
Why?
|
Cohort Studies | 2 | 2017 | 41335 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.050 |
Why?
|
Risk Factors | 3 | 2019 | 74359 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Prospective Studies | 2 | 2017 | 54303 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8552 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14660 | 0.050 |
Why?
|
Ischemia | 1 | 2010 | 1893 | 0.050 |
Why?
|
Survival Analysis | 1 | 2014 | 10182 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14495 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25942 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39261 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 22053 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 3484 | 0.040 |
Why?
|
Communication | 1 | 2013 | 3849 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.040 |
Why?
|
Eye | 1 | 2023 | 710 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3505 | 0.040 |
Why?
|
Myocardium | 1 | 2010 | 4700 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2010 | 4938 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2021 | 595 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2021 | 755 | 0.030 |
Why?
|
Operating Rooms | 1 | 2023 | 789 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5791 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4925 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3568 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40165 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5643 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29658 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2116 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20509 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1869 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12103 | 0.020 |
Why?
|
Haplorhini | 1 | 2010 | 529 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2010 | 1543 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 877 | 0.020 |
Why?
|
Animals | 2 | 2017 | 167963 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 1649 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2056 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20080 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.010 |
Why?
|
Protein Kinases | 1 | 2010 | 1612 | 0.010 |
Why?
|
Phylogeny | 1 | 2010 | 2775 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6965 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12965 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8158 | 0.010 |
Why?
|
Protein Binding | 1 | 2010 | 9335 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11071 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15620 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23711 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 8056 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9585 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81208 | 0.000 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_